Report cover image

Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jan 27, 2023
Length 100 Pages
SKU # LPI17669963

Description

Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Osteoarthritis Gene Therapy Industry Forecast” looks at past sales and reviews total world Osteoarthritis Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Gene Therapy sales for 2023 through 2029. With Osteoarthritis Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Gene Therapy industry.

This Insight Report provides a comprehensive analysis of the global Osteoarthritis Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Gene Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Gene Therapy.

The global Osteoarthritis Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Osteoarthritis Gene Therapy players cover Flexion, GeneQuine, Novartis, Smith & Nephew, Genascence, Kolon TissueGene, Sanofi, Paraxel and Medipost, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Gene Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Synovium Injection
Cartilage Injection

Segmentation by application
Hospitals and clinics
Orthopedic Centers
Assisted living Facilities
Nursing Homes
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

100 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Gene Therapy Market Size 2018-2029
2.1.2 Osteoarthritis Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Osteoarthritis Gene Therapy Segment by Type
2.2.1 Synovium Injection
2.2.2 Cartilage Injection
2.3 Osteoarthritis Gene Therapy Market Size by Type
2.3.1 Osteoarthritis Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Osteoarthritis Gene Therapy Segment by Application
2.4.1 Hospitals and clinics
2.4.2 Orthopedic Centers
2.4.3 Assisted living Facilities
2.4.4 Nursing Homes
2.4.5 Ambulatory Surgical Centers
2.4.6 Others
2.5 Osteoarthritis Gene Therapy Market Size by Application
2.5.1 Osteoarthritis Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Osteoarthritis Gene Therapy Market Size Market Share by Application (2018-2023)
3 Osteoarthritis Gene Therapy Market Size by Player
3.1 Osteoarthritis Gene Therapy Market Size Market Share by Players
3.1.1 Global Osteoarthritis Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Osteoarthritis Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Osteoarthritis Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Osteoarthritis Gene Therapy by Regions
4.1 Osteoarthritis Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Osteoarthritis Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Osteoarthritis Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Osteoarthritis Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Osteoarthritis Gene Therapy Market Size Growth (2018-2023)
5 Americas
5.1 Americas Osteoarthritis Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Osteoarthritis Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Osteoarthritis Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osteoarthritis Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Osteoarthritis Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Osteoarthritis Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Osteoarthritis Gene Therapy by Country (2018-2023)
7.2 Europe Osteoarthritis Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Osteoarthritis Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Osteoarthritis Gene Therapy Market Forecast
10.1 Global Osteoarthritis Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Osteoarthritis Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Osteoarthritis Gene Therapy Forecast
10.1.3 APAC Osteoarthritis Gene Therapy Forecast
10.1.4 Europe Osteoarthritis Gene Therapy Forecast
10.1.5 Middle East & Africa Osteoarthritis Gene Therapy Forecast
10.2 Americas Osteoarthritis Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Osteoarthritis Gene Therapy Market Forecast
10.2.2 Canada Osteoarthritis Gene Therapy Market Forecast
10.2.3 Mexico Osteoarthritis Gene Therapy Market Forecast
10.2.4 Brazil Osteoarthritis Gene Therapy Market Forecast
10.3 APAC Osteoarthritis Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Osteoarthritis Gene Therapy Market Forecast
10.3.2 Japan Osteoarthritis Gene Therapy Market Forecast
10.3.3 Korea Osteoarthritis Gene Therapy Market Forecast
10.3.4 Southeast Asia Osteoarthritis Gene Therapy Market Forecast
10.3.5 India Osteoarthritis Gene Therapy Market Forecast
10.3.6 Australia Osteoarthritis Gene Therapy Market Forecast
10.4 Europe Osteoarthritis Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Osteoarthritis Gene Therapy Market Forecast
10.4.2 France Osteoarthritis Gene Therapy Market Forecast
10.4.3 UK Osteoarthritis Gene Therapy Market Forecast
10.4.4 Italy Osteoarthritis Gene Therapy Market Forecast
10.4.5 Russia Osteoarthritis Gene Therapy Market Forecast
10.5 Middle East & Africa Osteoarthritis Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Osteoarthritis Gene Therapy Market Forecast
10.5.2 South Africa Osteoarthritis Gene Therapy Market Forecast
10.5.3 Israel Osteoarthritis Gene Therapy Market Forecast
10.5.4 Turkey Osteoarthritis Gene Therapy Market Forecast
10.5.5 GCC Countries Osteoarthritis Gene Therapy Market Forecast
10.6 Global Osteoarthritis Gene Therapy Forecast by Type (2024-2029)
10.7 Global Osteoarthritis Gene Therapy Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Flexion
11.1.1 Flexion Company Information
11.1.2 Flexion Osteoarthritis Gene Therapy Product Offered
11.1.3 Flexion Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Flexion Main Business Overview
11.1.5 Flexion Latest Developments
11.2 GeneQuine
11.2.1 GeneQuine Company Information
11.2.2 GeneQuine Osteoarthritis Gene Therapy Product Offered
11.2.3 GeneQuine Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GeneQuine Main Business Overview
11.2.5 GeneQuine Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Osteoarthritis Gene Therapy Product Offered
11.3.3 Novartis Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Smith & Nephew
11.4.1 Smith & Nephew Company Information
11.4.2 Smith & Nephew Osteoarthritis Gene Therapy Product Offered
11.4.3 Smith & Nephew Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Smith & Nephew Main Business Overview
11.4.5 Smith & Nephew Latest Developments
11.5 Genascence
11.5.1 Genascence Company Information
11.5.2 Genascence Osteoarthritis Gene Therapy Product Offered
11.5.3 Genascence Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Genascence Main Business Overview
11.5.5 Genascence Latest Developments
11.6 Kolon TissueGene
11.6.1 Kolon TissueGene Company Information
11.6.2 Kolon TissueGene Osteoarthritis Gene Therapy Product Offered
11.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Kolon TissueGene Main Business Overview
11.6.5 Kolon TissueGene Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Osteoarthritis Gene Therapy Product Offered
11.7.3 Sanofi Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Paraxel
11.8.1 Paraxel Company Information
11.8.2 Paraxel Osteoarthritis Gene Therapy Product Offered
11.8.3 Paraxel Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Paraxel Main Business Overview
11.8.5 Paraxel Latest Developments
11.9 Medipost
11.9.1 Medipost Company Information
11.9.2 Medipost Osteoarthritis Gene Therapy Product Offered
11.9.3 Medipost Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Medipost Main Business Overview
11.9.5 Medipost Latest Developments
11.10 Mundipharma
11.10.1 Mundipharma Company Information
11.10.2 Mundipharma Osteoarthritis Gene Therapy Product Offered
11.10.3 Mundipharma Osteoarthritis Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mundipharma Main Business Overview
11.10.5 Mundipharma Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us